§ 15-601

Maryland § 15-601

• Jurisdiction: Maryland
• Article ghg: Health - General
• Title: 15

Text

(a) In this subtitle the following words have the meanings indicated.

(b) “Board” means the State Board of Pharmacy.

(c) “Dispense” means to provide:

(1) A prescription drug or medical supply in accordance with a prescription; or

(2) An over–the–counter drug or medical supply.

(d) “Drop–off site” means a pharmacy, other health care facility, or other entity participating in a drug donation or repository program and designated by the Board that:

(1) Has voluntarily agreed to accept donated prescription drugs, over–the–counter drugs, or medical supplies;

(2) Is located within the State or in another state; and

(3) Does not have a final disciplinary order issued against it by a health occupations board.

(e) “Eligible patient” means an individual who, through self–attestation, is indigent, uninsured, underinsured, or enrolled in a public health benefits program.

(f) “Program” means the Prescription Drug Repository Program.

(g) “Repository” means a licensed pharmacy that:

(1) If the licensed pharmacy is located in the State, does not have a final disciplinary order issued against it by the Board of Pharmacy;

(2) Has voluntarily agreed to participate in the Program;

(3) Is located in the State or in another state; and

(4) Has been approved by the Board to:

(i) Accept donated prescription drugs, over–the–counter drugs, or medical supplies from a designated drop–off site;

(ii) Dispense the donated prescription drugs, over–the–counter drugs, or medical supplies to eligible patients; or

(iii) Dispose of prescription drugs, over–the–counter drugs, or medical supplies not accepted for dispensing to eligible patients.

(h) “Tamper–evident packaging” means a packaging system that:

(1) May involve an immediate–container and closure system, secondary–container or carton system, tertiary–container system, or other combination of systems intended to provide a visual indication of package integrity;

(2) May contain unit–dose or multi–dose contents; and

(3) Has one or more indicators or barriers to entry that:

(i) If breached or missing, can reasonably be expected to provide visible evidence to consumers that tampering has occurred; and

(ii) If handled in a reasonable manner during manufacture, distribution, or retail display, is designed to remain intact.